You are here

migraines

Migraine Breakthrough: Not So Fast

Forbes

Wed, 06/6/18 - 09:49 pm

monoclonal antibodies

Thanks to lower-than-expected price, ICER backs Amgen's Aimovig—but only after other meds fail

Fierce Pharma

Fri, 06/1/18 - 11:40 am

Will Amgen’s migraine win and 5th thumbs-up for Prolia drive enough growth? Nope, says analyst

Fierce Pharma

Tue, 05/22/18 - 06:06 pm

Migraine prevention drug could be worth $1 to $2 billion over next five years: Wall Street analyst

CNBC

Sat, 05/19/18 - 11:30 am

Amgen’s new migraine drug will cost 30 percent less than Wall Street expected

Stat

Thu, 05/17/18 - 09:48 pm

Amgen's Aimovig won its first-in-class migraine nod. Will payers step up to the $6,900 price?

Fierce Pharma

Thu, 05/17/18 - 09:42 pm

Lilly's CGRP drug succeeds in 'worst kind of migraine'

Biopharma Dive

Tue, 05/15/18 - 09:09 pm

cluster headaches

Migraine drug delay would compound Teva's troubles

Reuters

Thu, 05/3/18 - 11:05 pm

Teva Pharmaceutical

Eyeing blockbuster migraine market, Allergan unloads second set of positive PhIII results for ubrogepant

Endpoints

Fri, 04/27/18 - 10:09 am

clinical trials

New Data For Alder BioPharmaceuticals' Eptinezumab Shows Long-Term Reduction in Episodic Migraine

CP Wire

Wed, 04/25/18 - 11:06 am

Alder BioPharmaceutical

Express Scripts targets Amgen, Lilly migraine drugs in pricing shift

Reuters

Tue, 04/24/18 - 10:47 pm

Express Scripts

Racing Allergan, Biohaven Touts Migraine Drug Data, But Shares Sink

Xconomy

Mon, 03/26/18 - 09:54 am

Biohaven Pharmaceuticals

Will Teva's Fremanezumab Be Delayed due to Troubles at Celltrion?

Market Realist

Mon, 03/26/18 - 09:43 am

Teva Pharmaceutical

Migraine maven Lilly finds 'understanding gap' between patients, nonpatients in new survey

Fierce Pharma

Mon, 03/5/18 - 09:45 am

Antidepressant-Migraine Drug Combination Found Less Risky Than Believed

Forbes

Wed, 02/28/18 - 06:51 pm

antidepressants

Top drugmakers are counting on two hot drug fields—migraine and NASH—but payers are ready to rumble

Fierce Pharma

Thu, 02/22/18 - 11:28 pm

Teva Pharmaceutical

Gilead Sciences

Intercept Pharma

Novartis Expects FDA and EMA Approvals for Aimovig in 2018

Yahoo/Market Realist

Wed, 02/21/18 - 09:47 am

Will Allergan cannibalize Botox with ubrogepant?

Biopharma Dive

Fri, 02/9/18 - 10:06 am

Teva's Turnarond: Is It Ever Or Never?

Forbes

Thu, 02/8/18 - 11:53 pm

Teva Pharmaceutical

In latest blow to Teva, CGRP migraine med delayed while rivals race towards the finish line

Endpoints

Thu, 02/8/18 - 09:40 am

Teva Pharmaceutical

Pages